Kent Thudium

1PUBLICATIONS
8CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Aug 18, 2022
Preclinical Characterization of Relatlimab, a Human LAG-3-Blocking Antibody, Alone or in Combination with Nivolumab.

Kent Thudium, Mark Selby, Julie A Zorn

Pageof 1

Frequent Collaborators

1 joint publications

Mark Selby

1 joint publications

Julie A Zorn

1 joint publications

Gregory Rak

1 joint publications

Xi-Tao Wang